Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients.

GM2, GD2, and GD3 gangliosides are expressed on the surface of human melanoma cells and represent potential targets for immunological control of melanoma growth by monoclonal antibodies and active immunization. The immunogenicity of GM2 was investigated by analyzing the humoral immune response of me...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Proc Natl Acad Sci U S A
Principais autores:	Livingston, P O, Natoli, E J, Calves, M J, Stockert, E, Oettgen, H F, Old, L J
Formato:	Artigo
Idioma:	Inglês
Publicado em:	National Academy of Sciences 1987
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC304770/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3472242/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.84.9.2911
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!